EMC
77
6
TROW
54
-2
UNP
40
-3
NEM
50
2
MCO
78
3
BBY
48
2
CME
56
-3
NKE
42
6
BLK
63
-4
EFX
46
2
EQR
40
-2
PNR
72
3
HCA
44
-2
T
45
-2
A
41
-3
RRC
63
8
BK
68
-3
ITW
58
-4
FLR
52
4
APA
37
2
EMC
77
6
TROW
54
-2
UNP
40
-3
NEM
50
2
MCO
78
3
BBY
48
2
CME
56
-3
NKE
42
6
BLK
63
-4
EFX
46
2
EQR
40
-2
PNR
72
3
HCA
44
-2
T
45
-2
A
41
-3
RRC
63
8
BK
68
-3
ITW
58
-4
FLR
52
4
APA
37
2
Financhill
Back

RBC Quant US Dividend Leaders ETF (CAD) Vs. Aligos Therapeutics Industry Stock Comparison

Buy
61

RUD.TO
RBC Quant US Dividend Leaders ETF (CAD)

Last Price:
25.96
Seasonality Move:
3.76%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Buy
61
RBC Quant US Dividend Leaders ETF (CAD) (RUD.TO) is a Buy

Is RBC Quant US Dividend Leaders ETF (CAD) a Buy, Sell or Hold?

  • The current RBC Quant US Dividend Leaders ETF (CAD) [RUD.TO] share price is $25.96. The Score for RUD.TO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • RUD.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RUD.TO Stock Price Chart

What is RBC Quant US Dividend Leaders ETF (CAD)'s stock price today?

  • The RBC Quant US Dividend Leaders ETF (CAD) share price today is $25.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RUD.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RUD.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.29 Buy
Relative Strength Index (14 RSI): 63.17 Buy
Chaikin Money Flow: 692 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.38 - 25.96) Buy
Bollinger Bands (100): (22.83 - 25.19) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

RUD.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.99 Sell
20-day SMA: 25.73 Buy
50-day SMA: 25.04 Buy
200-day SMA: 22.8 Buy
8-day EMA: 25.93 Buy
20-day EMA: 25.72 Buy
50-day EMA: 25.07 Buy
200-day EMA: 22.88 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

RBC Quant US Dividend Leaders ETF (CAD) Earnings Growth & RUD.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

RBC Quant US Dividend Leaders ETF (CAD) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):